is a partner located at the CMS Hamburg office, a member of the CMS life sciences/intellectual property team and co-head of the cannabis subgroup of the World Law Group. His clients are mainly globally active pharmaceutical and medical devices companies. He advises on regulatory issues, competition law and corporate business development, life sciences agreements and transactions in the life sciences sector. Jörn's special focus lies on the advice on regulatory issues concerning the liberalisation of the market for medicinal cannabis (such as regulatory structures for new businesses, applications for authorisations and advertising) and CBD products. Latest publication: Comment on the judgment ECJ C-663/18 (A&R 2020, 284).
Chambers and Partners make no representation or endorsement of the quality and services supplied
by companies or firms that may be found on this website. In no event will Chambers and Partners
be liable for any damages including, without limitation, indirect or consequential damages,
or any damages whatsoever arising from use or loss of use, data, or profits, whether in action
of contract, negligence or other tort action, arising out of or in connection with the use
of the website.